BIOTECanada Opens Canada Pavilion at BIO 2026 Amid Major Policy Momentum for Canadian Biotech
BIOTECanada officially opened the Canada Pavilion today at the BIO International Convention in San Diego, serving as the central hub for Canadian biotechnology companies to showcase their strengths and connect with global partners.
The opening comes at a pivotal moment for Canada’s biotechnology and life sciences sector. Over the past year, the sector has moved into the centre of several major federal priorities, from investment and tax competitiveness to health security, AI, and defence-related innovation. Recent measures, including reforms to the Scientific Research and Experimental Development (SR&ED) tax incentive, the new Venture and Growth Capital Catalyst Initiative, Health Emergency Readiness Canada, and the recognition of life sciences in Canada’s Defence Industrial Strategy and national AI strategy, reflect the growing recognition of biotechnology as a strategic national asset and an important driver of Canada’s long-term competitiveness.
Throughout BIO 2026, BIOTECanada will lead international engagements with partners from several continents, including country-focused discussions, roundtables, and sector-specific programming. These efforts support a broader goal: strengthening Canada’s biotechnology sector at home while helping Canadian companies diversify partnerships and build opportunities in markets around the world.
